Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Proposed rule impacts health insurer operations

A proposed rule would implement several changes in how health insurers operate under the Patient Protection and Affordable Care Act. Issued by the Centers for Medicare & Medicaid Services, the rule will be published in the Federal Register on Dec. 7.

Maryland P4P programs paying off

Two pay-for-performance (P4P) programs implemented in Maryland are showing how state-level efforts to set payment rates are influencing provider behavior and improving patient outcomes, according to research published in the December issue of Health Affairs. 

FDA looks to speed device approval with new partnership

The FDA is entering a public-private partnership with the Medical Device Innovation Consortium (MDIC) to help speed the development, assessment and review of new medical devices.

70% of voters have strong appetite for cutting federal health spending

Approximately 70 percent of voters believe reining in high healthcare costs should be a top post-election priority, according to an online survey of 1,200 conducted by PricewaterhouseCoopers.

ACOs are 'far from proving their value'

Accountable care organizations taking on a variety of forms are becoming more active in the healthcare landscape, but they’re far from proving their value, according to a report published by market researcher KLAS and consulting firm Leavitt Partners.

Report: ACOs grow, covering 10% of U.S. patients

Accountable care organizations (ACOs) appear to be gaining traction in the healthcare system, covering up to 10 percent of patients, and some early adopters are successfully transforming themselves into more efficient health networks, according to a Nov. 29 report published by Oliver Wyman. 

OIG: Flawed procedures for detecting inaccurate MU payments

The Office of the Inspector General (OIG) doubts the Centers for Medicare & Medicaid Services’ (CMS) ability to oversee the Meaningful Use (MU) program and offered recommendations to strengthen the program’s integrity in a November report.

FDA exec talks agency's role in disaster relief post-Sandy

When storms like Hurricane Sandy hit, the Federal Emergency Management Agency assumes the center stage in disaster relief, but it’s not the only federal agency providing emergency support. When natural disasters strike, the FDA works behind the scenes to address the harmful effects.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup